Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation

J Immunol. 2006 Jul 15;177(2):1160-70. doi: 10.4049/jimmunol.177.2.1160.

Abstract

Daxx has been shown to play an essential role in type I IFN-mediated suppression of B cell development and apoptosis. Recently, we demonstrated that Tyk2 is directly involved in IFN signaling for the induction and translocation of Daxx, which may result in growth arrest and/or apoptosis of B lymphocyte progenitors. To clarify the molecular mechanisms of how Daxx acts on growth suppression of B lymphocytes, we examined functions of a sumoylation-defective Daxx KA mutant (Daxx K630/631A), which substituted Lys 630 and Lys 631 to Ala. Importantly, Daxx KA localized in the cytoplasm, whereas wild-type Daxx localized in the nucleus. Murine pro-B cell line Ba/F3 expressing Daxx KA revealed a resistance to the IFN-induced growth suppression. It is noteworthy that treatment with an exportin inhibitor, leptomycin B, resulted in nuclear localization of Daxx KA and recovery of the IFN-induced growth suppression in Ba/F3 cells. Moreover, Daxx KA decreased the binding potential to promyelocytic leukemia protein (PML), and overexpression of PML recruited Daxx KA into PML oncogenic domains. Notably, a Daxx-small ubiquitin-related modifier fusion protein exhibited increased nuclear localization and ability to suppress cell growth in Ba/F3 cells. These results demonstrate that the IFN-induced growth suppression of B lymphocytes requires nuclear localization of Daxx through its sumoylation and proper interactions with PML.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / genetics
  • Alanine / genetics
  • Amino Acid Substitution / genetics
  • Animals
  • B-Lymphocytes / cytology*
  • B-Lymphocytes / metabolism*
  • B-Lymphocytes / physiology
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Carrier Proteins / physiology
  • Cell Line
  • Cell Line, Tumor
  • Co-Repressor Proteins
  • Cytoplasm / genetics
  • Cytoplasm / metabolism
  • Growth Inhibitors / antagonists & inhibitors
  • Growth Inhibitors / physiology*
  • HeLa Cells
  • Humans
  • Interferons / physiology*
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Intracellular Signaling Peptides and Proteins / physiology
  • Lysine / genetics
  • Mice
  • Molecular Chaperones
  • Neoplasm Proteins / metabolism
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Nuclear Proteins / physiology
  • Promyelocytic Leukemia Protein
  • Receptors, Glucocorticoid / physiology*
  • Small Ubiquitin-Related Modifier Proteins / metabolism*
  • Transcription Factors / metabolism
  • Transcriptional Activation*
  • Tumor Suppressor Proteins / metabolism
  • Ubiquitin-Conjugating Enzymes / physiology
  • Up-Regulation / physiology

Substances

  • Carrier Proteins
  • Co-Repressor Proteins
  • Daxx protein, mouse
  • Growth Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Molecular Chaperones
  • Neoplasm Proteins
  • Nuclear Proteins
  • Pml protein, mouse
  • Promyelocytic Leukemia Protein
  • Receptors, Glucocorticoid
  • Small Ubiquitin-Related Modifier Proteins
  • Transcription Factors
  • Tumor Suppressor Proteins
  • PML protein, human
  • Interferons
  • Ubiquitin-Conjugating Enzymes
  • ubiquitin-conjugating enzyme UBC9
  • Lysine
  • Alanine